Given the high disease burden of infectious diseases worldwide, with communicable diseases still accounting for most deaths, medical imaging can play an important role in the diagnosis and monitoring of infectious diseases.
Imaging provides some fundamental advantages namely, that it is non-invasive and provides results relatively rapidly.
Also, given the variety of modalities like Xray, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and molecular imaging such as positron emission tomography (PET) and single photon emission computed tomography (SPECT), imaging has the potential to provide both basic as well as highly sophisticated information about the disease processes.
We think at Imavita that the development of preclinical models of infectious diseases associated with in vivo and/or ex vivo imaging are strategic to accelerate development of future new treatments.

We are working actually on the following infectious diseases models:

Urinary Tract Infections models:

  • Acute Urinary Tract Infections
    where infection is evaluated on few days after initiation of infection models
  • Reccurrent Urinary Tract Infections (rUTI)
    where infection is evaluated on weeks after initiation of infection models

Acne infectious models:

  • Infection with P. acnes
  • Deactivated P. acnes injection to normal mice

Wound healing / Infected wounds:

  • Linked to dermatology models, wound healing with specific infectious bacteria (opportunist or pathogen) is of importance

These models are still on development
Do not hesitate to contact us if you need more information on these models.

CIR _ Research Tax Credit Imavita